Literature DB >> 12908771

Foamy virus vectors.

A Mergia1, M Heinkelein.   

Abstract

Gene therapy is a promising novel treatment for a variety of human diseases. Successful application of gene therapy requires the availability of vehicles with the ability to efficiently deliver and express genes. Viral vectors are efficient means of transferring a gene of interest into target cells. Current available vehicles for gene transfer are either inefficient or potentially unsafe for human gene therapy applications. Foamy viruses offer a fresh alternative vector system for gene transfer with the potential to overcome the concerns of the current vectors. Foamy viruses are nonpathogenic and have a broad host range with the ability to infect various types of cells from different species. Foamy virus replication is distinct and may provide an edge for foamy virus vector usage over other retroviral vectors. These features offer the foamy vectors unique opportunities to deliver several genes into a number of different cell types in vivo safely and efficiently. The principal problems for the design of foamy virus vectors have been solved, and several foamy virus vectors that efficiently transduce a variety of cell types are available. This chapter reviews specific features of foamy virus vector systems and recent advances in the development and use of these vectors.

Entities:  

Mesh:

Year:  2003        PMID: 12908771     DOI: 10.1007/978-3-642-55701-9_6

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  15 in total

1.  Foamy virus vector integration sites in normal human cells.

Authors:  Grant D Trobridge; Daniel G Miller; Michael A Jacobs; James M Allen; Hans-Peter Kiem; Rajinder Kaul; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-20       Impact factor: 11.205

2.  Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain.

Authors:  Anja Duda; Daniel Lüftenegger; Thomas Pietschmann; Dirk Lindemann
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  Advances in Gene Delivery Systems.

Authors:  Kenya Kamimura; Takeshi Suda; Guisheng Zhang; Dexi Liu
Journal:  Pharmaceut Med       Date:  2011-10-01

4.  Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.

Authors:  Michael Aaron Goodman; Paritha Arumugam; Devin Marie Pillis; Anastacia Loberg; Mohammed Nasimuzzaman; Danielle Lynn; Johannes Christiaan Maria van der Loo; Phillip Joseph Dexheimer; Mehdi Keddache; Thomas Roy Bauer; Dennis Durand Hickstein; David William Russell; Punam Malik
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

5.  Improved primate foamy virus vectors and packaging constructs.

Authors:  Martin Heinkelein; Marco Dressler; Gergely Jármy; Matthias Rammling; Horst Imrich; Jana Thurow; Dirk Lindemann; Axel Rethwilm
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Treatment of canine leukocyte adhesion deficiency by foamy virus vectors expressing CD18 from a PGK promoter.

Authors:  T R Bauer; E M Olson; Y Huo; L M Tuschong; J M Allen; Y Li; T H Burkholder; D W Russell
Journal:  Gene Ther       Date:  2011-01-13       Impact factor: 5.250

7.  Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site.

Authors:  Helga Eizert; Pálma Bander; Péter Bagossi; Tamás Sperka; Gabriella Miklóssy; Péter Boross; Irene T Weber; József Tözsér
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

8.  Inhibition of mouse hepatocyte apoptosis via anti-Fas ribozyme.

Authors:  Min Zhang; Wei He; Fang Liu; Ping Zou; Juan Xiao; Zhao-Dong Zhong; Zhong-Bo Hu
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

9.  The foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus.

Authors:  Yung-Tsun Lo; Tao Tian; Peter E Nadeau; Jeonghae Park; Ayalew Mergia
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

10.  Viral and nonviral delivery systems for gene delivery.

Authors:  Nouri Nayerossadat; Talebi Maedeh; Palizban Abas Ali
Journal:  Adv Biomed Res       Date:  2012-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.